MMP20 levels in adenocarcinoma grade II of the prostate were notably higher than in other prostatic neoplasms, including adenocarcinoma grade III, transitional cell carcinoma, leiomyoma, benign prostatic hyperplasia, and chronic prostatitis (Figure 1B). The gene discussed is MMP20; the disease is benign prostatic hyperplasia.